View in EDS HTML Full Text PDF Full Text

Efficacy of beinaglutide in the treatment of hepatic steatosis in type 2 diabetes patients with nonalcoholic fatty liver disease: A randomized, open-label, controlled trial.

Saved in:
Bibliographic Details
Title: Efficacy of beinaglutide in the treatment of hepatic steatosis in type 2 diabetes patients with nonalcoholic fatty liver disease: A randomized, open-label, controlled trial.
Authors: Fan Y; Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.; Department of Endocrinology and Metabolism, Minhang Hospital, Fudan University, Shanghai, China., Xia M; Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China., Yan H; Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China., Li X; Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China., Chang X; Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.
Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Feb; Vol. 26 (2), pp. 772-776. Date of Electronic Publication: 2023 Nov 17.
Publication Type: Randomized Controlled Trial; Letter
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37975640
AccessLevel: 2
PubType: Report
PubTypeId: report
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy of beinaglutide in the treatment of hepatic steatosis in type 2 diabetes patients with nonalcoholic fatty liver disease: A randomized, open-label, controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fan+Y%22">Fan Y</searchLink>; Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.; Department of Endocrinology and Metabolism, Minhang Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Xia+M%22">Xia M</searchLink>; Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Yan+H%22">Yan H</searchLink>; Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Chang+X%22">Chang X</searchLink>; Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100883645%22">Diabetes, obesity & metabolism</searchLink> [Diabetes Obes Metab] 2024 Feb; Vol. 26 (2), pp. 772-776. <i>Date of Electronic Publication: </i>2023 Nov 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100883645 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1463-1326 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214628902%22">14628902 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes Obes Metab <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37975640
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/dom.15359
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 772
    Titles:
      – TitleFull: Efficacy of beinaglutide in the treatment of hepatic steatosis in type 2 diabetes patients with nonalcoholic fatty liver disease: A randomized, open-label, controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fan Y
      – PersonEntity:
          Name:
            NameFull: Xia M
      – PersonEntity:
          Name:
            NameFull: Yan H
      – PersonEntity:
          Name:
            NameFull: Li X
      – PersonEntity:
          Name:
            NameFull: Chang X
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2024 Feb
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1463-1326
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Diabetes, obesity & metabolism
              Type: main
ResultId 1